| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $727.3M | +10.1% |
| Cost of Revenue | $413.0M | +11.5% |
| Gross Profit | $314.3M | +8.3% |
| R&D Expense | $37.1M | +19.0% |
| SG&A Expense | $273.3M | +5.2% |
| Operating Income | -$115.9M | -25.8% |
| Pre-tax Income | -$110.3M | -36.7% |
| Income Tax | -$2.2M | -15.1% |
| Net Income | -$108.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $159.6M | -56.5% |
| Accounts Receivable | $159.2M | +5.8% |
| Inventory | $28.6M | +6.8% |
| Current Assets | $376.3M | -36.9% |
| Total Assets | $1.36B | -17.0% |
| Current Liabilities | $88.3M | -70.7% |
| Long-term Debt | $341.9M | -36.8% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $5.2M | -25.5% |
| Capital Expenditures | $27.0M | -34.2% |
| Investing Cash Flow | -$12.3M | -196.0% |
| Financing Cash Flow | -$200.3M | -4411.0% |
| Free Cash Flow | -$21.8M | +36.0% |
| -37.2% |
| Total Liabilities |
| $523.3M |
| -28.9% |
| Stockholders' Equity | $836.6M | -7.3% |